A. P. Basavarajappa
Research Subjects
Research Interests
A. P. Basavarajappa has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Nabarun Mukhopadhyay
Department of Chemical Sciences (Natural Products), National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India
1 shared publication Prabha Hullatti
1 shared publication- Prabha Hullatti
Department of Pharmacy, Banasthali Vidyapith, Rajasthan, India
1 shared publication - Saraswati Patel
Department of Pharmacology, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, (SIMATS-Deemed University), Thandalam, Chennai, 602105 Tamil Nadu India
1 shared publication
Latest Publications
- Open Access
- 1 June 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 1-6
ROLE OF PLANT-BASED FLAVONOIDS AS DRUG CANDIDATES FOR INFLAMMATORY BOWEL DISEASE-A SHORT REVIEW
Inflammatory Bowel Disease (IBD) is a chronic disorder caused due to several factors. Out of these, inflammation is one of the major causative factors, and several inflammatory markers, like pro-inflammatory cytokines enzymes play an essential role in the progression and development of IBD. The existing therapies against IBD have severe adverse effects, and drug resistance can also occur. Hence, novel therapies against IBD need to be developed for the treatment and prevention of IBD. Natural products, specifically flavonoids, can be an excellent alternative to get better therapeutic efficacy. Hence, flavonoids can be utilized more bitterly as a drug candidate for IBD. Our review work mainly discussed the potential flavonoids and their role in treating IBD and also focussed on it by inhibiting inflammatory markers.
- 1 June 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 1-6
Open AccessROLE OF PLANT-BASED FLAVONOIDS AS DRUG CANDIDATES FOR INFLAMMATORY BOWEL DISEASE-A SHORT REVIEW
Inflammatory Bowel Disease (IBD) is a chronic disorder caused due to several factors. Out of these, inflammation is one of the major causative factors, and several inflammatory markers, like pro-inflammatory cytokines enzymes play an essential role in the progression and development of IBD. The existing therapies against IBD have severe adverse effects, and drug resistance can also occur. Hence, novel therapies against IBD need to be developed for the treatment and prevention of IBD. Natural products, specifically flavonoids, can be an excellent alternative to get better therapeutic efficacy. Hence, flavonoids can be utilized more bitterly as a drug candidate for IBD. Our review work mainly discussed the potential flavonoids and their role in treating IBD and also focussed on it by inhibiting inflammatory markers.